Understand the source comparison
Best Peptides After Breast Augmentation: Research Compound Comparison
BPC-157 Upregulates VEGF; activates FAK-paxillin pathway for fibroblast migration 250–500mcg daily (subcutaneous) ~4 hours 40–60% faster collagen synthesis in controlled wound models (Journal of Tissue Engineering, 2023) Best for vascularization and early-phas
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Upregulates VEGF; activates FAK-paxillin pathway for fibroblast migration
- 250–500mcg daily (subcutaneous)
- ~4 hours
- 40–60% faster collagen synthesis in controlled wound models (Journal of Tissue Engineering, 2023)
- Best for vascularization and early-phase tissue repair. Requires twice-daily dosing for stable levels
- TB-500 (Thymosin Beta-4)
- Binds actin to enable cell migration; downregulates IL-6 and TNF-alpha
- 2–5mg twice weekly (loading), then 2mg weekly (maintenance)
- ~10 days
- Reduces fibrosis and inflammatory cytokine expression in surgical wound models
- Most forgiving dosing schedule; strongest anti-inflammatory and anti-fibrotic profile
- GHK-Cu (Copper Peptide)
- Activates lysyl oxidase for collagen cross-linking; enhances superoxide dismutase (antioxidant)
- 1–3mg daily (subcutaneous or topical)
- ~8–12 hours
- Improves collagen organization and reduces oxidative stress markers in scar tissue studies
- Critical for collagen maturation phase. Topical formulations work for surface scars but not deep capsule remodeling
- These peptides target different phases of wound healing. Using all three in sequence covers the full recovery timeline more effectively than single-compound protocols. Vascularization (BPC-157) must occur before cellular migration (TB-500), which must occur before stable collagen matrices form (GHK-Cu).